ArticleIntegrative cancer therapies

Synergistic Effect of HAD-B1 and Osimertinib Against Gefitinib Resistant HCC827 Non-Small Cell Lung Cancer Cells.

Eun-Ju Ko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.